企業プロフィール
COMPASS Pathways Plc 株価・ニュース・カタリスト
- ティッカー:
- CMPS
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United Kingdom
株価パフォーマンス
14.20 USD (+6.53%)
終値
最終更新: 2026年8月24日
1.8B USD
時価総額
株価変動の要因
As of Aug 24, 2026, CMPS closed up 6.53% at $14.20. No new same-company headline was identified in the current news window.
企業概要
事業概要
COMPASS Pathways is a neuroscience company focused on psychedelic-assisted therapy and depression. Its story is centered on whether a novel mental-health paradigm can be translated into regulated medicine.
所在地とセクター分類
Headquartered in the United Kingdom and listed on NASDAQ as an ADR, COMPASS sits in specialty neuroscience biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, regulatory progress, and the commercial viability of a new treatment model for depression.
バイオ業界での位置付け
COMPASS is a high-catalyst CNS name whose value is heavily tied to clinical and regulatory outcomes.
今後のカタリスト
- Compass Pathways’s key catalyst is COMP360 in treatment-resistant depression, with the next clinical and regulatory steps doing most of the work. The market will react quickly if the psilocybin story keeps building toward a viable commercial path.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。